[1] 刘俊川.自体游离非血管化腓骨移植修复大段骨缺损的应用研究[D]. 石家庄:河北医科大学, 2010.[2] 吴治林. 个体化组织工程骨修复人长骨缺损的回顾性对比研究[D]. 重庆:第三军医大学, 2014.[3] Peng H, Huard J. Stem cells in the treatment of muscle and connective tissue diseases. Curr Opin Pharmacol. 2003; 3(3): 329-333.[4] 王呈,曾炳芳.骨移植替代材料在创伤骨科的应用[J]. 国际骨科学杂志, 2012, 33(1):37-38.[5] 丁立峰,周振东,杨军,等. 骨形态发生蛋白2基因转染的兔骨髓间充质干细胞复合聚乳酸-聚己内酯支架体外构建载基因仿生骨的实验研究[J].中国矫形外科杂志,2013,21(9): 918-923.[6] 崔岗,周岱,刘义荣,等. EH型复合人工骨材料在颅骨修补中的应用[J].中国血液流变学杂志,2001,11(4):275-276.[7] Fernández Vallone VB, Romaniuk MA, Choi H, et al. Mesenchymal stem cells and their use in therapy: what has been achieved. Differentiation. 2013;85(1-2):1-10.[8] Wang GP, Levine BL, Binder GK, et al. Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells. Mol Ther. 2009;17(5): 844-850.[9] Chieregato K, Albiero E, Castegnaro S, et al. A study on mutual interaction between cytokine induced killer cells and umbilical cord-derived mesenchymal cells: Implication for their in-vivo use. Blood Cells Mol Dis. 2012;49(3-4):159-165.[10] 李庆庆,王大平,熊建义,等. Runx2 重组慢病毒感染骨髓间充质干细胞并促进其成骨分化的研究[J].中国临床解剖学杂志, 2015, 33(3): 311-315.[11] Dalle Carbonare L, Innamorati G, Valenti MT. Transcription factor Runx2 and its application to bone tissue engineering. Stem Cell Rev. 2012;8(3):891-897.[12] Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev. 2013;19(3):254-263.[13] 马珊珊,崔渊博,姚宁,等. sirt2基因高表达对人脐带间充质干细胞衰老的抑制作用[J].郑州大学学报:医学版, 2016,51(1): 10-14.[14] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408.[15] Mahmoudifar N, Doran PM. Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends Biotechnol. 2012;30(3):166-176.[16] 李松岭,李宏捷,李秋芝,等.自体骨移植与生物材料修复下颌骨缺损的比较[J].口腔医学研究,2002,18(3):188-190[17] 于艳秋,任海琴,云伟,等.人类脐血来源的间充质干细胞向软骨和成骨细胞分化的实验研究[J].生物医学工程学杂志,2008, 25(6): 1385-1389.[18] Scheller EL, Krebsbach PH, Kohn DH. Tissue engineering: state of the art in oral rehabilitation. J Oral Rehabil. 2009; 36(5):368-389.[19] Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 1996;334(2):77-81.[20] Xie G, Sun J, Zhong G, et al. Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitro. J Mater Sci Mater Med. 2010;21(6):1875-1880.[21] Grgurevic L, Macek B, Mercep M, et al. Bone morphogenetic protein (BMP)1-3 enhances bone repair. Biochem Biophys Res Commun. 2011;408(1):25-31.[22] Yazici C, Takahata M, Reynolds DG, et al. Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. Mol Ther. 2011;19(8): 1416-1425.[23] Guillot PV, De Bari C, Dell'Accio F, et al. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation. 2008;76(9): 946-957.[24] Handschel J, Berr K, Depprich RA, et al. Induction of osteogenic markers in differentially treated cultures of embryonic stem cells. Head Face Med. 2008;4:10.[25] Maegawa N, Kawamura K, Hirose M, et al. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med. 2007;1(4):306-313.[26] Varkey M, Kucharski C, Haque T, et al. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin Orthop Relat Res. 2006;443:113-123.[27] Wyatt LE, Chung CY, Carlsen B, et al. Bone morphogenetic protein-2 (BMP-2) and transforming growth factor-beta1 (TGF-beta1) alter connexin 43 phosphorylation in MC3T3-E1 Cells. BMC Cell Biol. 2001;2:14.[28] Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11(6):471-491.[29] 毕杨,黄佳祎,吴明军,等.β-catenin腺病毒载体的构建及鉴定[J].重庆医科大学学报,2007,32(6):561-564. |